Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter Study
Background: This study aimed to investigate prognostic factors for predicting the survival of patients with extensive-disease-stage small-cell lung cancer treated with chemoimmunotherapy. Methods: Patients were classified according to overall survival (OS): favorable corresponded to an OS ≥ 24 month...
        Saved in:
      
    
          | Main Authors: | Takashi Hatori, Takeshi Numata, Toshihiro Shiozawa, Manato Taguchi, Hirofumi Sakurai, Tomohiro Tamura, Jun Kanazawa, Hiroaki Tachi, Kyoko Kondo, Kunihiko Miyazaki, Norihiro Kikuchi, Koichi Kurishima, Hiroaki Satoh, Nobuyuki Hizawa | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | MDPI AG
    
        2024-10-01 | 
| Series: | Current Oncology | 
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/31/11/482 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Potential Involvement of IL-17F in Asthma        
                          
 by: Kyoko Ota, et al.
 Published: (2014-01-01)
- 
                
                    First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin        
                          
 by: Soichiro Sue, et al.
 Published: (2017-01-01)
- 
                
                    Response to: Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”        
                          
 by: Soichiro Sue, et al.
 Published: (2018-01-01)
- 
                
                    In-hospital cardiac rehabilitation and clinical outcomes in patients with acute myocardial infarction after percutaneous coronary intervention: a retrospective cohort study        
                          
 by: Hiroaki Iijima, et al.
 Published: (2020-09-01)
- 
                
                    Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy        
                          
 by: Meng Wang, et al.
 Published: (2022-02-01)
 
       